Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Buy
56
MNTL Quote, Financials, Valuation and Earnings
Last price:
$23.15
Seasonality move
:
2.3%
Day range:
$23.27 - $23.27
52-week range:
$19.86 - $27.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
36
Avg. volume:
117
1-year change:
-14.21%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
$23.27 | -- | -- | -- | $0.26 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$32.20 | -- | -- | -- | $0.14 | 0.9% | -- |
|
CANC
Tema Oncology ETF
|
$26.47 | -- | -- | -- | $0.73 | 1.89% | -- |
|
HRTS
Tema Heart & Health ETF
|
$28.58 | -- | -- | -- | $0.47 | 0.5% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$28.03 | -- | -- | -- | $0.00 | 0% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$27.47 | -- | -- | -- | $0.51 | 1.66% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | 0.615 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.588 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 0.844 | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | 0.652 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.335 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.403 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
Tema Neuroscience and Mental Health ETF vs. Competitors
-
Which has Higher Returns MNTL or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About MNTL or AGNG?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is MNTL or AGNG More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.736, suggesting its less volatile than the S&P 500 by 26.45%.
-
Which is a Better Dividend Stock MNTL or AGNG?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.9% to investors and pays a quarterly dividend of $0.14 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or AGNG?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns MNTL or CANC?
Tema Oncology ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About MNTL or CANC?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Tema Oncology ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is MNTL or CANC More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or CANC?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Tema Oncology ETF offers a yield of 1.89% to investors and pays a quarterly dividend of $0.73 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or CANC?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns MNTL or HRTS?
Tema Heart & Health ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Tema Heart & Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- HRTSTema Heart & Health ETF-- -- -- -
What do Analysts Say About MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Heart & Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Tema Heart & Health ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Tema Heart & Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 HRTSTema Heart & Health ETF0 0 0 -
Is MNTL or HRTS More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Heart & Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Tema Heart & Health ETF offers a yield of 0.5% to investors and pays a quarterly dividend of $0.47 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Tema Heart & Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or HRTS?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Tema Heart & Health ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Tema Heart & Health ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Tema Heart & Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Tema Heart & Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- HRTSTema Heart & Health ETF-- -- -- --
-
Which has Higher Returns MNTL or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About MNTL or HTEC?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is MNTL or HTEC More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.148, suggesting its more volatile than the S&P 500 by 14.776%.
-
Which is a Better Dividend Stock MNTL or HTEC?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or HTEC?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns MNTL or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About MNTL or MEDX?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is MNTL or MEDX More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or MEDX?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Horizon Kinetics Medical ETF offers a yield of 1.66% to investors and pays a quarterly dividend of $0.51 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or MEDX?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
